Also listed on JMD Pharma Creativity, LLC, an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Jun 8, 2042 · High confidence
20-year base term ends Jun 8, 2042
Held by Atai Therapeutics Inc.
Filed Jun 8, 2022 as application 17/835,764 · Granted Mar 12, 2024
Base term, 20 years from filing
Today
2022
2042
Clock starts
Jun 8, 2022
Jun 8, 2022
Term ends
Jun 8, 2042
Jun 8, 2042
Granted
Mar 12, 2024
Mar 12, 2024
base term
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 8, 2022, when this application, 17/835,764, was filed | Jun 8, 2042 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 8, 2042 | High confidence |
This family
| US 11,926,574 | this patent Jun 2042 | Jun 2042 |
| US 12,351,537 | In force Jun 2042 | Jun 2042 |
| Application 19/216,245 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 11, 2022 Reel 61735, frame 409 | Difrancesco, Benjamin Robert | Cyclica Inc. | Assignment of Assignor's Interest |
| Nov 15, 2022 Reel 61781, frame 844 | Short, Glenn | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Nov 15, 2022 Reel 61782, frame 275 | Khan, Tanweer A. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Dec 14, 2022 Reel 62084, frame 881 | Perni, Robert B. | JMD Pharma Creativity, LLC | Assignment of Assignor's Interest |
| Dec 14, 2022 Reel 62090, frame 870 | Cyclica Inc. | Entheogenix Biosciences, Inc. | Assignment of Assignor's Interest |
| Jun 29, 2023 Reel 64120, frame 46 | JMD Pharma Creativity, LLC | Atai Life Sciences US, Inc. | Assignment of Assignor's Interest |
| Jul 21, 2023 Reel 64342, frame 687 | Atai Life Sciences US, Inc. | Atai Life Sciences AG | Assignment of Assignor's Interest |
| Jul 25, 2023 Reel 64379, frame 762 | Atai Life Sciences AG | Entheogenix Biosciences, Inc. | Assignment of Assignor's Interest |
| Jan 2, 2024 Reel 65992, frame 782 | Entheogenix Biosciences, Inc. | Atai Therapeutics Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Jun 2042
Term ends Jun 8, 2042. Maintenance fees still fall due before then
Citations
4
later US patents cite this one
Fewer than half of the utility patents granted in 2024 in our data have been cited yet, so we show the count and do not rank on it.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.